617 related articles for article (PubMed ID: 34472809)
1. Epidemiology and Antifungal Susceptibility of Candida Species causing Blood Stream Infections: An Eastern India Perspective.
Chakraborty M; Banu H; Gupta MK
J Assoc Physicians India; 2021 Aug; 69(8):11-12. PubMed ID: 34472809
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. To study the profile of
Lamba M; Sharma D; Sharma R; Vyas A; Mamoria V
J Matern Fetal Neonatal Med; 2021 Aug; 34(16):2655-2659. PubMed ID: 31581861
[TBL] [Abstract][Full Text] [Related]
4. Candidemia in intensive care unit patients: a one year study from a tertiary care center in South India.
Giri S; Kindo AJ; Kalyani J
J Postgrad Med; 2013; 59(3):190-5. PubMed ID: 24029196
[TBL] [Abstract][Full Text] [Related]
5. Alarming Increase of Azole-Resistant Candida Causing Blood Stream Infections in Oncology Patients in Egypt.
El-Mahallawy HA; Abdelfattah NE; Wassef MA; Abdel-Hamid RM
Curr Microbiol; 2023 Oct; 80(11):362. PubMed ID: 37796322
[TBL] [Abstract][Full Text] [Related]
6. The emergence of non-albicans candidemia and evaluation of HiChrome Candida differential agar and VITEK2 YST® platform for differentiation of Candida bloodstream isolates in teaching hospital Kandy, Sri Lanka.
Kothalawala M; Jayaweera JAAS; Arunan S; Jayathilake A
BMC Microbiol; 2019 Jun; 19(1):136. PubMed ID: 31226938
[TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibility and virulence determinants profile of candida species isolated from patients with candidemia.
Dawoud AM; Saied SA; Torayah MM; Ramadan AE; Elaskary SA
Sci Rep; 2024 May; 14(1):11597. PubMed ID: 38773138
[TBL] [Abstract][Full Text] [Related]
8. Antifungal susceptibility of Candida species isolated from patients with candidemia in southern Taiwan, 2007-2012: impact of new antifungal breakpoints.
Chen YC; Kuo SF; Chen FJ; Lee CH
Mycoses; 2017 Feb; 60(2):89-95. PubMed ID: 27621210
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of Candida blood stream infections: experience of a tertiary care centre in North India.
Chander J; Singla N; Sidhu SK; Gombar S
J Infect Dev Ctries; 2013 Sep; 7(9):670-5. PubMed ID: 24042103
[TBL] [Abstract][Full Text] [Related]
10. Changing trends in epidemiology and antifungal susceptibility patterns of six bloodstream Candida species isolates over a 12-year period in Kuwait.
Khan Z; Ahmad S; Al-Sweih N; Mokaddas E; Al-Banwan K; Alfouzan W; Al-Obaid I; Al-Obaid K; Asadzadeh M; Jeragh A; Joseph L; Varghese S; Vayalil S; Al-Musallam O
PLoS One; 2019; 14(5):e0216250. PubMed ID: 31042770
[TBL] [Abstract][Full Text] [Related]
11. Changing trends of Candidemia and antifungal susceptibility pattern in a tertiary health care centre.
Chaudhary U; Goel S; Mittal S
Infect Disord Drug Targets; 2015; 15(3):171-6. PubMed ID: 26411557
[TBL] [Abstract][Full Text] [Related]
12. A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
Rodriguez L; Bustamante B; Huaroto L; Agurto C; Illescas R; Ramirez R; Diaz A; Hidalgo J
PLoS One; 2017; 12(4):e0175172. PubMed ID: 28419092
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.
Tadec L; Talarmin JP; Gastinne T; Bretonnière C; Miegeville M; Le Pape P; Morio F
Mycoses; 2016 May; 59(5):296-303. PubMed ID: 26806101
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of candidemia in NICE area, France: A five-year study of antifungal susceptibility and mortality.
Vannini M; Emery S; Lieutier-Colas F; Legueult K; Mondain V; Retur N; Gastaud L; Pomares C; Hasseine L
J Mycol Med; 2022 Mar; 32(1):101210. PubMed ID: 34768155
[TBL] [Abstract][Full Text] [Related]
15. Clinical manifestations of candidemia caused by uncommon Candida species and antifungal susceptibility of the isolates in a regional hospital in Taiwan, 2007-2014.
Liu WL; Lai CC; Li MC; Wu CJ; Ko WC; Hung YL; Tang HJ; Hsueh PR
J Microbiol Immunol Infect; 2019 Aug; 52(4):612-619. PubMed ID: 28886952
[TBL] [Abstract][Full Text] [Related]
16. Study of Candidemia and its Antifungal Susceptibility Profile at the University Hospital of Montevideo, Uruguay.
Carbia M; Medina V; Bustillo C; Martínez C; González MP; Ballesté R
Mycopathologia; 2023 Dec; 188(6):919-928. PubMed ID: 37314581
[TBL] [Abstract][Full Text] [Related]
17. Echinocandin Susceptibility Profile of Fluconazole Resistant Candida Species Isolated from Blood Stream Infections.
Deorukhkar SC; Saini S
Infect Disord Drug Targets; 2016; 16(1):63-8. PubMed ID: 26648186
[TBL] [Abstract][Full Text] [Related]
18. Candida tropicalis is the most prevalent yeast species causing candidemia in Algeria: the urgent need for antifungal stewardship and infection control measures.
Megri Y; Arastehfar A; Boekhout T; Daneshnia F; Hörtnagl C; Sartori B; Hafez A; Pan W; Lass-Flörl C; Hamrioui B
Antimicrob Resist Infect Control; 2020 Apr; 9(1):50. PubMed ID: 32264966
[TBL] [Abstract][Full Text] [Related]
19. The Epidemiology and Susceptibility of Candidemia in Jerusalem, Israel.
Israel S; Amit S; Israel A; Livneh A; Nir-Paz R; Korem M
Front Cell Infect Microbiol; 2019; 9():352. PubMed ID: 31681629
[No Abstract] [Full Text] [Related]
20. Epidemiological Trends of Fungemia in Greece with a Focus on Candidemia during the Recent Financial Crisis: a 10-Year Survey in a Tertiary Care Academic Hospital and Review of Literature.
Siopi M; Tarpatzi A; Kalogeropoulou E; Damianidou S; Vasilakopoulou A; Vourli S; Pournaras S; Meletiadis J
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
